News

A new life-science fund said it raised €240.3 million – and promptly announced its first two investments.

Europe looks increasingly likely to follow America’s lead and require drug companies to test their products in children. But Europe's pharma lack the resources to carry out drug trials in children — so industry and patients will have to rely on the skills developed in academic centres.

Nuala’s Moran’s roundup of news and views in the management of intellectual assets Helpdesk

Avidex is teaming up with diabetes specialists at King’s College London to work on a new approach to treating the Type I form of the disease.

Imperial College London's technology commercialisation company is betting on a spin-out company, deltaDOT, to speed detection and decrease costs of finding new proteins for drug discovery.

Partnerships: An EU project aims to design road-hardened microchips in a fast-changing market.

Energy: The Manchester “bobber” is using the power of ocean waves to find a lower-cost route to alternative energy.

Scientists love to complicate things; and if you're not in the same field, or – worse – are in business or investment, then it's easy to get lost. Enter the Science|Business Quick Guides to some of the hottest fields of science and technology…

Michael Kenward's roundup of new studies, reports and tools for the business of science

Barry Fox thinks that the patent system is deliberately designed to make it hard to find out anything.